These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30215367)

  • 1. Reducing harm in the treatment of multidrug-resistant tuberculosis.
    Reuter A; Furin J
    Lancet; 2018 Sep; 392(10150):797-798. PubMed ID: 30215367
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis.
    Sougakoff W
    Clin Microbiol Infect; 2011 Jun; 17(6):800-5. PubMed ID: 21682800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
    Achar J; Berry C; Herboczek K; Parpieva N; Tillyashaykhov MN; Tigay ZN; Khamraev A; Velivela K; Seddon JA; du Cros P
    Emerg Infect Dis; 2015 Nov; 21(11):2105-6. PubMed ID: 26488556
    [No Abstract]   [Full Text] [Related]  

  • 4. Better and safer treatment for multidrug-resistant tuberculosis.
    Farmer PE
    Lancet; 2018 Sep; 392(10150):798-800. PubMed ID: 30215368
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug-resistant tuberculosis: pharmacokinetic and pharmacodynamic science.
    Alffenaar JC; Migliori GB; Gumbo T
    Lancet Infect Dis; 2017 Sep; 17(9):898. PubMed ID: 28845791
    [No Abstract]   [Full Text] [Related]  

  • 6. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico.
    Zazueta-Beltran J; Muro-Amador S; Flores-Gaxiola A; Llausas-Magaña E; León-Sicairos N; Canizalez-Roman A
    J Infect; 2007 Apr; 54(4):411-2. PubMed ID: 16730800
    [No Abstract]   [Full Text] [Related]  

  • 7. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
    Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
    Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
    Cox HS; Sibilia K; Feuerriegel S; Kalon S; Polonsky J; Khamraev AK; Rüsch-Gerdes S; Mills C; Niemann S
    N Engl J Med; 2008 Nov; 359(22):2398-400. PubMed ID: 19038891
    [No Abstract]   [Full Text] [Related]  

  • 9. Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis.
    Pérez-Lago L; Lirola MM; Navarro Y; Herranz M; Ruiz-Serrano MJ; Bouza E; García-de-Viedma D
    Emerg Infect Dis; 2015 Nov; 21(11):2098-100. PubMed ID: 26488258
    [No Abstract]   [Full Text] [Related]  

  • 10. Multidrug-resistant tuberculosis.
    Di Perri G; Vento S; Concia E; Cazzadori A
    N Engl J Med; 1996 Jan; 334(4):268; author reply 268-9. PubMed ID: 8532010
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidrug-resistant tuberculosis and migration to Europe.
    van der Werf MJ; Hollo V; Ködmön C
    Clin Microbiol Infect; 2017 Aug; 23(8):578-579. PubMed ID: 28232165
    [No Abstract]   [Full Text] [Related]  

  • 12. Peritoneal tuberculosis due to multidrug-resistant Mycobacterium tuberculosis.
    Esposito S; Bosis S; Canazza L; Tenconi R; Torricelli M; Principi N
    Pediatr Int; 2013 Apr; 55(2):e20-2. PubMed ID: 23679177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolones in multidrug-resistant tuberculosis.
    Mohapatra PR
    Am J Respir Crit Care Med; 2004 Oct; 170(8):920-1. PubMed ID: 15475406
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of children exposed to multidrug-resistant Mycobacterium tuberculosis.
    Seddon JA; Godfrey-Faussett P; Hesseling AC; Gie RP; Beyers N; Schaaf HS
    Lancet Infect Dis; 2012 Jun; 12(6):469-79. PubMed ID: 22373591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention.
    Almeida D; Rodrigues C; Udwadia ZF; Lalvani A; Gothi GD; Mehta P; Mehta A
    Clin Infect Dis; 2003 Jun; 36(12):e152-4. PubMed ID: 12802779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistant tuberculosis: a continuing crisis.
    Burki T
    Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
    [No Abstract]   [Full Text] [Related]  

  • 17. Scale-up of diagnostics for multidrug resistant tuberculosis.
    Caws M; Ha DT
    Lancet Infect Dis; 2010 Oct; 10(10):656-8. PubMed ID: 20813586
    [No Abstract]   [Full Text] [Related]  

  • 18. Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe.
    van der Werf MJ; Ködmön C; Catchpole M
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28572128
    [No Abstract]   [Full Text] [Related]  

  • 19. Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe.
    Heldal E; Van Deun A; Chiang CY; Rieder HL
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28572127
    [No Abstract]   [Full Text] [Related]  

  • 20. [New drugs against multidrug-resistant tuberculosis].
    Bouvet É
    Rev Prat; 2014 Sep; 64(7):896-7. PubMed ID: 25362760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.